285 related articles for article (PubMed ID: 28033278)
21. Recent Developments in the Classification, Evaluation, Pathophysiology, and Management of Scleroderma Renal Crisis.
Ghossein C; Varga J; Fenves AZ
Curr Rheumatol Rep; 2016 Jan; 18(1):5. PubMed ID: 26711696
[TBL] [Abstract][Full Text] [Related]
22. A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature.
Akoglu H; Atilgan GK; Ozturk R; Yenigun EC; Gonul II; Odabas AR
Rheumatol Int; 2009 Aug; 29(10):1223-9. PubMed ID: 19048256
[TBL] [Abstract][Full Text] [Related]
23. Scleroderma renal crisis is still a life-threatening syndrome.
Stratta P; Besso L; Ferrero S; Canavese C; Hollo S; Ottone S; Sandri L; Thea A; Mazzucco G
Ren Fail; 1996 Jul; 18(4):567-74. PubMed ID: 8875681
[TBL] [Abstract][Full Text] [Related]
24. [Case Report: Atypical posterior reversible encephalopathy syndrome (PRES) and thrombotic microangiopathy (TMA) in a hemodialysis patient with ANCA-associated vasculitis: a case report].
Sakai R; Sakurai S; Okada T; Takahashi T; Hayakawa S; Koji H; Iwasaki M; Iwamoto K
Nihon Naika Gakkai Zasshi; 2016 Feb; 105(2):275-9. PubMed ID: 27228724
[No Abstract] [Full Text] [Related]
25. A 45-Year-Old Man with Scleroderma Renal Crisis Associated with a History of Systemic Sclerosis Sine Scleroderma.
Hansrivijit P; Omeonu KF; Lawal HO; Gangireddy M; Gadhiya KP; Dhatt RS
Am J Case Rep; 2020 Nov; 21():e927030. PubMed ID: 33230093
[TBL] [Abstract][Full Text] [Related]
26. Recurring posterior reversible encephalopathy syndrome in a patient with polymyositis/systemic sclerosis overlap syndrome triggered by scleroderma renal crisis.
Kobatake M; Ishimaru N; Kanzawa Y; Seto H; Kinami S
Eur J Rheumatol; 2019 Jul; 6(3):158-160. PubMed ID: 30986168
[TBL] [Abstract][Full Text] [Related]
27. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
[TBL] [Abstract][Full Text] [Related]
28. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review.
Smets GJ; Loyson T; Van Paesschen W; Demaerel P; Nackaerts K
Acta Clin Belg; 2018 Oct; 73(5):382-388. PubMed ID: 29173113
[TBL] [Abstract][Full Text] [Related]
29. Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.
Farrukh L; Steen VD; Shapiro L; Mehta S
Semin Arthritis Rheum; 2023 Dec; 63():152256. PubMed ID: 37689027
[TBL] [Abstract][Full Text] [Related]
30. Posterior reversible encephalopathy syndrome following elevated mean arterial pressures for cervical spinal cord injury.
Zimering JH; Mesfin A
J Spinal Cord Med; 2018 Jan; 41(1):111-114. PubMed ID: 27917700
[TBL] [Abstract][Full Text] [Related]
31. Scleroderma renal crisis or thrombotic thrombocytopenic purpura: seeing through the masquerade.
Keeler E; Fioravanti G; Samuel B; Longo S
Lab Med; 2015; 46(2):e39-44. PubMed ID: 26023003
[TBL] [Abstract][Full Text] [Related]
32. Normotensive scleroderma renal crisis in a patient with progressive systemic sclerosis: case report and review of literature.
Saeed F; Parke A
Conn Med; 2011 Feb; 75(2):83-7. PubMed ID: 21476377
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Clinical Manifestations, Laboratory, Neuroimaging Findings, and Outcomes in Children With Posterior Reversible Encephalopathy Syndrome (PRES) in Children With and Without Renal Disease.
Virojtriratana T; Hongsawong N; Wiwattanadittakul N; Katanyuwong K; Chartapisak W; Sanguansermsri C
Pediatr Neurol; 2022 Sep; 134():37-44. PubMed ID: 35810661
[TBL] [Abstract][Full Text] [Related]
34. Posterior reversible encephalopathy syndrome in children with kidney disease.
Gavrilovici C; Miron I; Voroneanu L; Bădărau S; Stârcea M
Int Urol Nephrol; 2017 Oct; 49(10):1793-1800. PubMed ID: 28836059
[TBL] [Abstract][Full Text] [Related]
35. Posterior Reversible Encephalopathy Syndrome in adult sickle-cell patients: Case series and literature review.
Vargas A; Testai FD
J Clin Neurosci; 2019 Dec; 70():249-250. PubMed ID: 31447365
[TBL] [Abstract][Full Text] [Related]
36. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls.
Guillevin L; Bérezné A; Seror R; Teixeira L; Pourrat J; Mahr A; Hachulla E; Agard C; Cabane J; Vanhille P; Harle JR; Deleveaux I; Mouthon L
Rheumatology (Oxford); 2012 Mar; 51(3):460-7. PubMed ID: 22087012
[TBL] [Abstract][Full Text] [Related]
37. Scleroderma renal crisis in tropical region: two senegalese cases.
Cisse MM; Seck SM; Oumar DA; Fall K; Lemrabott AT; Diallo M; Faye M; Faye M; Niang A; Diouf B
Pan Afr Med J; 2015; 21():46. PubMed ID: 26405482
[TBL] [Abstract][Full Text] [Related]
38. Importance of correctly interpreting magnetic resonance imaging to diagnose posterior reversible encephalopathy syndrome associated with HELLP syndrome: a case report.
Tetsuka S; Nonaka H
BMC Med Imaging; 2017 May; 17(1):35. PubMed ID: 28545408
[TBL] [Abstract][Full Text] [Related]
39. Clinical course of patients with scleroderma renal crisis treated with captopril.
Zawada ET; Clements PJ; Furst DA; Bloomer HA; Paulus HE; Maxwell MH
Nephron; 1981; 27(2):74-8. PubMed ID: 7022235
[TBL] [Abstract][Full Text] [Related]
40. Management review of scleroderma renal crisis: An update with practical pointers.
Foocharoen C; Tonsawan P; Pongkulkiat P; Anutrakulchai S; Mahakkanukrauh A; Suwannaroj S
Mod Rheumatol; 2023 Jan; 33(1):12-20. PubMed ID: 35349704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
